OBI Pharma Inc. (OBI) is a global clinical stage oncology company that is headquartered in Taiwan. The company also has subsidiaries in the United States and Australia. It was founded in 2002 by Dr. Michael Chang, an accomplished biotech entrepreneur in the United States. Its stocks were issued publicly in 2012. Subsequently, the company was successfully listed on the Taipei Exchange (4174.TWO) in 2015.
OBI focuses on innovative research and development for cancer therapies and aims to develop “first-in-class” and “best-in-class” ground-breaking drugs. It aspires to market these drugs worldwide with a “Made in Taiwan” branding and to provide new treatment options for patients with unmet medical needs.
The core value of OBI lies in its passion to develop and deliver a portfolio of unique antibody-drug conjugates (ADC) drugs for patients, in addition to its promising Globo series (e.g., Globo H) of cancer therapeutic vaccines. This evolving portfolio includes a spectrum of cancer targets, such as TROP2, Nectin4, HER2, etc. These ADCs are built based on two distinct ADC technology platforms, each with different characteristics. Both platforms are customizable and offer a “plug-and-play” advantage through a specialized site-specific conjugation using a proprietary enzyme. With the added value of scalability, these “plug-and-play” technology platforms enable ADC development to be relatively simple and efficient.
OBI is interested in commercializing its ADC technology platforms and looks forward to collaborating with biotech and pharmaceutical companies by enabling “first-in-class” and “best-in-class” therapeutic candidates for further development.
Company Details
- Employees
- 133
- Address
- 6f., No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist.,,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.obipharma.com/
- Keywords
- Biotechnology, Oncology, Antibody-Drug Conjugate, Bispecific ADC, Dual Payload ADC, Active Immunotherapy.
- HQ
- Taipei City, TAIWAN
Obi Pharma Questions
Obi Pharma's website is https://www.obipharma.com/
Obi Pharma's LinkedIn profile is https://www.linkedin.com/company/obi-pharma
Obi Pharma has
133 employees.
View email and phone details for 133
employees at Obi Pharma.
Obi Pharma's industry is
Biotechnology Research
Obi Pharma's top competitors are
Bora Pharmaceuticals,
Eirgenix, Inc.,
Amaran Biotech,
Mycenax Biotech Inc.,
Obi Pharma Usa,
Pharmaessentia,
Global Bio & Investment Monthly,
Taimed Biologics,
Formosa Laboratories, Inc.,
Development Center For Biotechnology.
Obi Pharma's categories are Biotechnology Research
